Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
DarÃo GarcÃa-Carracedo, Maria Ãngeles Villaronga, Saúl Ãlvarez-Teijeiro, Francisco Hermida-Prado, Iñigo SantamarÃa, Eva Allonca, Laura Suárez-Fernández, Maria Victoria Gonzalez, Milagros BalbÃn, Aurora Astudillo, Pablo MartÃnez-Camblor, Gloria H. Su, Juan Pablo Rodrigo, Juana MarÃa GarcÃa-Pedrero
Published Apr 23, 2016 · Vol. 7, No. 20 · pp. 29780-29793
Cristina Magi-Galluzzi, Tara Maddala, Sara Moscovita Falzarano, Diana B. Cherbavaz, Nan Zhang, Dejan Knezevic, Phillip G. Febbo, Mark Lee, Hugh Jeffrey Lawrence, Eric A. Klein
Published Apr 22, 2016 · Vol. 7, No. 23 · pp. 33855-33865
Yang Su, Katharina Tatzel, Xuejun Wang, Brian Belt, Pratibha Binder, Lindsay Kuroki, Matthew A. Powell, David G. Mutch, William G. Hawkinsand, Dirk Spitzer
Published Apr 22, 2016 · Vol. 7, No. 21 · pp. 31534-31549